Efonidipine hydrochloride monoethanolate
|
|
|
- CAS-Nr.
- 111011-76-8
- Englisch Name:
- Efonidipine hydrochloride monoethanolate
- Synonyma:
- nz-105;Yifudipine;nz105ethanolate;Hydrochloride ethanol;EFONIDIPINE USP/EP/BP;r,p-oxide,monohydrochloride;Efonidipine HCl monoethanolate;efonidipinehydrochlorideethanolate;NZ-105 HYDROCHLORIDE MONOETHANOLATE;2-(phenyl(phenylmethyl)amino)ethyleste
- CBNumber:
- CB9317820
- Summenformel:
- C34H38N3O7P.C2H6O.ClH
- Molgewicht:
- 714.19
- MOL-Datei:
- 111011-76-8.mol
|
Efonidipine hydrochloride monoethanolate Eigenschaften
- Schmelzpunkt:
- 151° (dec)
- storage temp.
- Inert atmosphere,2-8°C
- L?slichkeit
- DMSO : 25 mg/mL (35.01 mM; Need ultrasonic)H2O : < 0.1 mg/mL (insoluble)
- Aggregatzustand
- Powder
- Farbe
- Light yellow to yellow
- InChIKey
- IKBJGZQVVVXCEQ-UHFFFAOYSA-N
- SMILES
- Cl.CCO.CC1=C(C(c2cccc(c2)[N+]([O-])=O)C(=C(C)N1)P3(=O)OCC(C)(C)CO3)C(=O)OCCN(Cc4ccccc4)c5ccccc5
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| WGK Germany |
WGK 1 |
|
|
| Speicherklasse |
11 - Combustible Solids |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung
|
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H361 |
Kann vermutlich die Fruchtbarkeit beeintr?chtigen oder das Kind im Mutterleib sch?digen. |
Reproduktionstoxizit?t |
Kategorie 2 |
Warnung |
|
P201, P202, P281, P308+P313, P405,P501 |
|
| Sicherheit |
| P201 |
Vor Gebrauch besondere Anweisungen einholen. |
| P202 |
Vor Gebrauch alle Sicherheitshinweise lesen und verstehen. |
| P281 |
Vorgeschriebene pers?nliche Schutzausrüstung verwenden. |
| P308+P313 |
BEI Exposition oder falls betroffen: ?rztlichen Rat einholen/?rztliche Hilfe hinzuziehen. |
| P405 |
Unter Verschluss aufbewahren. |
| P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
Efonidipine hydrochloride monoethanolate Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Efonidipine hydrochloride ethanol was first launched in Japan for the treatment of
essential severe and renal hypertension. As the fourteenth dihydropyridine (DHP)
calcium channel blocker to reach the market, it functions by binding to the DHP
receptors on voltage-dependent calcium channels to cause diuretic and natriuretic
actions in patients with essential hypertension. Its vasodilating and calcium
antagonist effects are very slow in onset and long-lasting in all types of
experimentally hypertensive models and the agent is reported to exhibit an improved
side effect profile compared with other drugs of the same class. This may be
explained by the slow and long-lasting inhibition of transmembrane Ca
+2 uptake,
which is accompanied by its very slow binding to and dissociation from the DHP
receptors. A recent study in cholesterol-fed rabbits suggested that efonidipine may
suppress the development of atherosclerosis without affecting the plasma lipids.
Clinical trials for angina, peetoris, and for cerebrovasodilatory disorders have been
reported.
Verwenden
Efonidipine Hydrochloride Monoethanolate is a potent inhibitor of the L-type calcium channel.
Biologische Aktivit?t
Selective blocker of L-type and T-type Ca 2+ channels. Displays minimal inhibition of N- and P/Q-type channels and no inhibition of R-type channels. R (-) and S (+)-enantiomers displays different channel selectivity; S (+)-Efonidipine blocks L-type and T-type channels whereas R (-)-Efonidipine displays selectivity for T-type channels. Exhibits antihypertensive activity.
Efonidipine hydrochloride monoethanolate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Efonidipine hydrochloride monoethanolate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 111)Lieferanten
111011-76-8()Verwandte Suche:
- Efonidipine hydrochloride monoethanolate
- Efonidipine Hydrochloride ethanol (1:1:1)
- 2-(phenyl(phenylmethyl)amino)ethyleste
- 3-pyridinecarboxylicacid,1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-1,3,2-dioxa
- efonidipinehydrochlorideethanolate
- nz-105
- nz105ethanolate
- r,p-oxide,monohydrochloride
- 5-(5,5-Dimethyl-2-oxido-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylicacid2-[phenyl(phenylmethyl)amino]ethylesterhydrochloridemonoethanolate
- Hydrochloride ethanol
- NZ-105 HYDROCHLORIDE MONOETHANOLATE
- EFONIDIPINE USP/EP/BP
- Ethanol, compd. with 2-(phenyl(phenylmethyl)amino)ethyl 5-(5,5-dimethyl-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate P-oxide monohydrochloride (1:1)
- 2-(Benzyl(phenyl)amino)ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate compound with ethanol (1:1) hydrochloride
- 2-(Benzyl(phenyl)amino)ethyl 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphinan-2-yl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate ethanol hydrochloride
- inhibit,Efonidipine hydrochloride monoethanolate,Ca channels,Ca2+ channels,Calcium Channel,Inhibitor
- 3-Pyridinecarboxylic acid, 5-(5,5-dimethyl-2-oxido-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-[phenyl(phenylmethyl)amino]ethyl ester, hydrochloride, compd. with ethanol (1:1:1)
- Efonidipine hydrochloride monoethanolate, 10 mM in DMSO
- Yifudipine
- Efonidipine HCl monoethanolate
- 111011-76-8
- C34H38N3O7P
- C34H38N3O7PHClC2H5OH
